Pharmacogenetic aspects of methotrexate in a cohort of Colombian patients with rheumatoid arthritis

Londono, J; Saldarriaga, EL; Rueda, JC; Giraldo-Bustos, R; Angarita, JI; Restrepo, L; Ballesteros-Munoz, J; Gonzalez, C; Ospina, MJ; Arias-Correal, S; Reyes-Martinez, V; Bernalmacias, S; Villota-Eraso, C; Santos-Moreno, P; Martinez-Rodriguez, N; Santos, AM

Santos, AM (corresponding author), Univ La Sabana, Rheumatol Dept, Grp Espondiloartropatias, Campus Puente Comun,Km 7, Chia 250001, Cundinamarca, Mexico.

BIOMEDICAL REPORTS, 2020; 13 (4):

Abstract

Methotrexate (MTX) is the most commonly used disease-modifying antirheumatic drug for the treatment of rheumatoid arthritis (RA). However, over time, ......

Full Text Link